KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Intangibles (2016 - 2025)

Amgen has reported Intangibles over the past 17 years, most recently at $22.3 billion for Q4 2025.

  • Quarterly results put Intangibles at $22.3 billion for Q4 2025, down 19.58% from a year ago — trailing twelve months through Dec 2025 was $22.3 billion (down 19.58% YoY), and the annual figure for FY2025 was $22.3 billion, down 19.58%.
  • Intangibles for Q4 2025 was $22.3 billion at Amgen, down from $23.1 billion in the prior quarter.
  • Over the last five years, Intangibles for AMGN hit a ceiling of $32.6 billion in Q4 2023 and a floor of $350.0 million in Q2 2025.
  • Median Intangibles over the past 5 years was $15.4 billion (2021), compared with a mean of $18.2 billion.
  • Biggest five-year swings in Intangibles: skyrocketed 119.92% in 2024 and later tumbled 98.84% in 2025.
  • Amgen's Intangibles stood at $15.2 billion in 2021, then rose by 5.91% to $16.1 billion in 2022, then soared by 102.99% to $32.6 billion in 2023, then fell by 15.14% to $27.7 billion in 2024, then decreased by 19.58% to $22.3 billion in 2025.
  • The last three reported values for Intangibles were $22.3 billion (Q4 2025), $23.1 billion (Q3 2025), and $350.0 million (Q2 2025) per Business Quant data.